Standout Papers

K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung 1990 2026 2002 2014 637
  1. K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung (1990)
    Robert J.C. Slebos, R.E. Kibbelaar et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 20 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
2020 StandoutNature
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
2019 StandoutScience
2 intermediate papers

Works of R.E. Kibbelaar being referenced

K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
1990 Standout

Author Peers

Author Last Decade Papers Cites
R.E. Kibbelaar 309 31 24 409 346 8 734
Hayley Robinson 301 75 18 304 229 8 703
Lucie Boerrigter 363 41 78 277 351 16 796
G. Celine Han 182 29 161 329 397 15 689
Jean Powers 415 68 81 262 325 12 741
Karin Mattson 298 12 17 288 267 10 622
Vanessa Cerisano 390 10 72 315 182 11 740
Tanaz Sharifnia 485 21 28 294 219 8 697
Leila Dardaei 321 28 24 338 275 13 607
W. M. Linehan 242 24 33 356 121 10 675
Johannes Schumann 227 33 47 153 281 8 800

All Works

Loading papers...

Rankless by CCL
2026